Home › Chronic Kidney Disease › New Jersey
Chronic Kidney Disease clinical trials in New Jersey
9 studies for Chronic Kidney Disease are looking for participants at sites in New Jersey.
Cities in New Jersey
A Phase III Renal Outcomes and Cardiovascular Mortality Study to Investigate the Efficacy and Safety of Baxdrostat in Combination With Dapagliflozin in Participants With Chronic Kidney Disease and High Blood Pressure
- Research Site, Eatontown
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Sep 25, 2026 · NCT06742723Study to Assess the Efficacy, Pharmacokinetics, Safety and Tolerability of Atrasentan in Pediatric Patients With Primary IgAN
- Hackensack Meridian Health, Neptune City
RecruitingPhase 3
Ages 2 to 18 · All sexes · Updated Sep 21, 2026 · NCT07498335A Study to Find Out How EMPAgliflozin is Tolerated and if it Helps Children and Adolescents With Chronic KIDNEY Disease (EMPA-KIDNEY® Kids)
- Jersey Shore University Medical Center, Neptune City
RecruitingPhase 3
Ages 2 to 17 · All sexes · Updated Sep 16, 2026 · NCT07107945A Study to Investigate Outcomes With Elecoglipron Compared With Placebo in Adult Participants With Chronic Kidney Disease.
- Research Site, Eatontown
- Research Site, Jersey City
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Sep 9, 2026 · NCT07753993A Study of Luspatercept in People With Anemia
- Memorial Sloan Kettering Basking Ridge (Limited Protocol Activities), Basking Ridge
- Memorial Sloan Kettering Monmouth (Limited Protocol Activities), Middletown
- Memorial Sloan Kettering Bergen (Limited Protocol Activities), Montvale
RecruitingPhase 2
Ages 18 and older · All sexes · Updated Jul 24, 2026 · NCT07725497SPYRAL GEMINI Pilot Study
- Virtua Our Lady of Lourdes Hospital, Camden
Recruiting
Ages 18 to 80 · All sexes · Updated Jun 24, 2026 · NCT06907147Rutgers University Study of the Genetics of Kidney Disease
- Rutgers, The State University of New Jersey, Piscataway
RecruitingObservational studyHealthy volunteers welcome
Ages 18 and older · All sexes · Updated Apr 24, 2026 · NCT07217535A Study to Evaluate the Safety and Effectiveness of the InnAVasc Arteriovenous Graft for Hemodialysis Access in Patients With End-Stage Renal Disease
- Rutgers, Newark
Recruiting
Ages 18 to 90 · All sexes · Updated Dec 22, 2025 · NCT04671771AK+ Guard™ Pilot Study in Chronic Kidney Disease: Outpatient Diagnostic Accuracy and Remote Monitoring
- Central Jersey Kidney Care - Hypertension & Nephrology Associates, Eatontown
RecruitingObservational study
Ages 22 and older · All sexes · Updated Oct 16, 2025 · NCT07210021From ClinicalTrials.gov, data retrieved Oct 5, 2026. Each study sets its own eligibility; the study team decides who can join.